• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗骨髓瘤细胞抗血清对免疫增强的作用。

Effect of antimyeloma cell antiserum on immunological enhancement.

作者信息

Hosokawa M, Mihich E, Watanabe T, Pressman D

出版信息

Cancer Res. 1975 Mar;35(3):591-5.

PMID:1116124
Abstract

Growth of Sarvoma 180 in AKR mice was enhanced by immunization with frozen-thawed homogenates of this tumor. Treatment of host mice with rabbit antimyeloma cell antiserum, either furing immunization or shortly after tumor implantation, resulted in a decreased incidence of tumor rejection or an increased rate of tumor growth. A slow-growing subline from a spontaneous, DBA/2Ha-DD mammary tumor is rejected after initial growth in DBA/2J mice. The incidence of rejection was reduced by treatment with the antiserum studied.

摘要

用该肿瘤的冻融匀浆对AKR小鼠进行免疫可增强肉瘤180的生长。在免疫期间或肿瘤植入后不久,用兔抗骨髓瘤细胞抗血清处理宿主小鼠,会导致肿瘤排斥发生率降低或肿瘤生长速率增加。来自自发的DBA/2Ha-DD乳腺肿瘤的一个生长缓慢的亚系在DBA/2J小鼠中初始生长后会被排斥。所研究的抗血清处理可降低排斥发生率。

相似文献

1
Effect of antimyeloma cell antiserum on immunological enhancement.抗骨髓瘤细胞抗血清对免疫增强的作用。
Cancer Res. 1975 Mar;35(3):591-5.
2
Development of resistance to MOPC-315 plasmacytoma after intralesional and intraperitoneal melphalan therapy of tumor-bearing BALB/c mice. I. Enhancement of in vivo rejection responses by combined chemotherapy-immunotherapy.荷瘤BALB/c小鼠经瘤内和腹腔注射美法仑治疗后对MOPC-315浆细胞瘤耐药性的发展。I. 联合化疗-免疫疗法增强体内排斥反应
J Natl Cancer Inst. 1982 Jun;68(6):963-9.
3
Fast- and slow-growing transplantable tumors derived from spontaneous mammary tumors of the DBA/2 Ha-DD mouse.源自DBA/2 Ha-DD小鼠自发性乳腺肿瘤的生长快和生长慢的可移植肿瘤。
Cancer Res. 1975 Oct;35(10):2657-62.
4
Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma.用针对次要组织相容性抗原不匹配的预免疫效应细胞进行细胞治疗小鼠乳腺癌。
J Immunother. 2001 Mar-Apr;24(2):114-21.
5
Cancer immunity after treatment of Ehrlich tumor with diphtheria toxin.
Cancer Res. 1974 Dec;34(12):3481-6.
6
Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.DBA/2淋巴瘤L1210及其亚系的差异抗原表达:同基因单克隆抗体所定义的与C3H乳腺肿瘤的交叉反应性。
Cancer Res. 1983 Jun;43(6):2592-9.
7
An experimental model for evaluation of factors in tumor escape from immunological attack.
Cancer Res. 1975 Mar;35(3):734-9.
8
Is immunosuppression at the tumor site mechanism of evasion of a systemic response?肿瘤部位的免疫抑制是逃避全身反应的机制吗?
J Med. 2003;34(1-6):3-14.
9
Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors.同基因眼内肿瘤免疫排斥的破坏性和非破坏性模式。
J Immunol. 1987 Jun 15;138(12):4515-23.
10
In vitro studies of allotype suppression in mice.小鼠同种异型抑制的体外研究。
Eur J Immunol. 1973 Oct;3(10):619-24. doi: 10.1002/eji.1830031005.